COVID-19 Mortality Rates Linked to Active Disease, ICU Deferral in AML, ALL, and MDS - Targeted Oncology
Patients with acute myeloid leukemia, acute lymphoblastic leukemia, and myelodysplastic syndrome had higher mortality rates after being diagnosed with COVID-19 than those with COVID-19 who did not have cancer.
Patients with acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and myelodysplastic syndrome (MDS) had higher mortality rates after being diagnosed with COVID-19 than those with COVID… [+4813 chars]
Read More
Other Stories in Health
- Peristaltic pumping motion found to trigger amyloid formation
- NIDUS-Family care package reduces dementia support costs
- SGEM Memes AI for Clinical Research
- UVA receives $9.3 million NIH grant for ketamine seizure treatment trial
- Childhood cancer: A growing concern
- 8 daily exercises to reduce cholesterol levels naturally and detox our body
- New biomarker can accurately predict outcomes in meningiomas and breast cancers
- Pollution shift: How truck electrification moves the burden to power plants
- In Robert F. Kennedy Jr, the US has put a conspiracy theorist in charge of public health
.png)
